Duloxetine (Cymbalta): A Potential Off-Label Treatment for Migraine
Posted on May 01 2023,

Click for the full list of the 50 uncommon migraine preventives
What is Duloxetine?
Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI). Therefore, it inhibits the reuptake of serotonin and norepinephrine.
As you can see in this picture, blocking the reuptake (termed reabsorption in the picture) of serotonin and norepinephrine will increase their concentration in the synapses and, therefore, the brain.
Duloxetine is a prescription medication that is FDA-approved for the treatment of major depressive disorder (MDD), generalized anxiety disorder (GAD), diabetic peripheral neuropathic pain (DPNP), fibromyalgia (FM), and chronic musculoskeletal pain. It is also sometimes used off-label for migraine prevention. Many of the aforementioned conditions are also comorbid conditions of migraine and hence why this medication may be more appealing for those patients.
How Does Duloxetine Work?
As we stated earlier, duloxetine works by inhibiting the reuptake of serotonin and norepinephrine thereby increasing their levels in the brain. It is important to note that SNRIs are more effective than SSRIs for migraine prevention although they are both used off-label.
Duloxetine as a Potential Treatment Option for Migraine
There are no randomized controlled trials for duloxetine, but smaller studies are available.
In one study, there was efficacy of duloxetine in patients with coexisting depression and medication overuse due to chronic migraine.
In another study, it was found that migraine prophylactic treatment with high-dose duloxetine may be effective in a nondepressed individual.
Potential Side Effects of Duloxetine
Common side effects of duloxetine include nausea, headache, dry mouth, insomnia, and constipation. If you experience any severe side effects or have concerns about taking this medication, it is important to speak with your healthcare provider.
There is an FDA black box warning against duloxetine as it carries an ncreased risk of suicidal thinking and behavior in children, adolescents, and young adults taking antidepressants for major depressive disorder (MDD) and other psychiatric disorders. Duloxetine is not approved for use in pediatric patients
Other Considerations for Duloxetine
Duloxetine is generally prescribed to those patients that cannot be prescribed venlafaxine.
It is important to talk to your neurologist when planning on stopping this medication.
Do not use duloxetine if you have used an MAO inhibitor in the past 14 days.
Risk of serotonin syndrome if used with triptans, but unlikely. Speak to your healthcare provider.
This is a cursory understanding of uncommon migraine medications. This is only to be used as a resource to go to your neurologist with.
Tue, May 06, 25
One Treatment, Two Conditions: Study Reveals Ajovy's Impact on Migraine and Depression
Fremanezumab (Ajovy) for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder Findings from the UNITE randomized clinical trial involving 353 patients with both migraine and depression Based...
Read MoreFri, May 02, 25
Blood Flow Changes Between Migraine Attacks
New research reveals increased cerebral blood flow in migraine patients between attacks. This 4D flow MRI study shows significant hemodynamic changes in the middle and posterior cerebral arteries, with blood...
Read MoreThu, May 01, 25
Migraine and Pregnancy: Understanding the Risks
Discover how migraine affects pregnancy outcomes: New meta-analysis reveals increased risks of preeclampsia and preterm birth. Essential reading for patients and clinicians.
Read More